文献速递乳腺癌放疗放疗物理与技术

Skagen Trial 1早期乳腺癌患者勾画与剂量计划的质量评估

Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1.
PubMed 文献 · Radiother Oncol · 2017-03-25

该研究对纳入随机Skagen Trial 1的早期乳腺癌患者进行质量评估(QA),评估靶区勾画和剂量参数与方案的偏差。共评估来自4个国家12个中心的88个计划,显示勾画一致性高,76%患者剂量结果无偏差,原始勾画与金标准剂量结果相当。

要点

  • 勾画一致性高,99%和96%患者靶区及危及器官勾画完整。
  • 76%患者剂量结果无偏差,乳腺/胸壁和CTVn_L2-4-interpectoral覆盖成功率分别为82%和95%。
  • 原始勾画与金标准勾画的剂量结果可比,观察者间变异性低。

核心结论

  • QA显示大多数患者方案依从性高且剂量覆盖充分。
  • 勾画的观察者间变异性低。
  • 无论原始或金标准分割,剂量参数均与方案一致。

研究设计与样本

  • 对随机Skagen Trial 1中随机选取的剂量计划进行质量评估,评估靶区勾画和剂量参数(Dmin、Dmax、D98%、D95%和D2%)与方案的偏差。
  • 根据ESTRO指南通过基于图谱的自动分割获得靶区勾画,并经中心批准作为金标准(GS)。
  • 评估包括来自4个国家12个中心的88个计划。

主要发现

  • Dice相似性评分显示轮廓勾画高度一致。
  • 99%和96%的患者具有完整的靶区和危及器官勾画。
  • 76%的患者未发现剂量结果偏差。
  • 82%和95%的患者分别成功覆盖乳腺/胸壁和CTVn_L2-4-interpectoral。
  • 原始勾画和金标准的剂量结果可比。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To report on a Quality assessment (QA) of Skagen Trial 1, exploring hypofractionation for breast cancer patients with indication for regional nodal radiotherapy. MATERIAL AND METHODS: Deviations from protocol regarding target volume delineations and dose parameters (Dmin, Dmax, D98%, D95% and D2%) from randomly selected dose plans were assessed. Target volume delineation according to ESTRO guidelines was obtained through atlas based automated segmentation and centrally approved as gold standard (GS). Dice similarity scores (DSC) with original delineations were measured. Dose parameters measured in the two delineations were reported to assess their dosimetric outcome. RESULTS: Assessment included 88 plans from 12 centres in 4 countries. DSC showed high agreement in contouring, 99% and 96% of the patients had a complete delineation of target volumes and organs at risk. No deviations in the dosimetric outcome were found in 76% of the patients, 82% and 95% of the patients had successful coverage of breast/chestwall and CTVn_L2-4-interpectoral. Dosimetric outcomes of original delineation and GS were comparable. CONCLUSIONS: QA showed high protocol compliance and adequate dose coverage in most patients. Inter-observer variability in contouring was low. Dose parameters were in harmony with protocol regardless original or GS segmentation.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Francolini G, Thomsen MS, Yates ES, et al. Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1. Radiother Oncol. 2017. PMID: 28351523. doi:10.1016/j.radonc.2017.03.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。